Publications by authors named "Xiangjing Shen"
Article Synopsis
- Mesenchymal stem cells (MSCs) show great potential as candidates for new drugs due to their immune regulation and ability to target tumors.
- They are being researched for applications in cancer therapy and treatment of inflammatory and fibrotic diseases.
- The review discusses various strategies for using MSCs in drug delivery and highlights current limitations and challenges in getting stem cell therapies into clinical use.
Ran GTPase activating protein 1 (RanGAP1) has been implicated in various diseases, but its role in colorectal cancer (CRC) progression remains unclear. Using tumor tissues and public databases, we found that RanGAP1 was significantly upregulated in CRC tissues and was associated with poor prognosis of patients. N6-methyladenosine (m6A) was found to play an important role in higher expression of RanGAP1.
View Article and Find Full Text PDF